MORRISON SCOTT W exercised options at TARSUS PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 9/16/2025ACC: 0001662426-25-000005
Director
Since Oct 2022
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
1.33K acquired · 1.33K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.33K
Price / share
—
Trade value
—
% of position
39.8%
9/15/2025
3.35K→4.68K
Total
Net shares
+1.33K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/15/2025 | M · Option Exercise | +1.33K | — | — | 39.8% | 3.35K | 4.68K |
| Total | +1.33K | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
1.33K shares
Shares
−1.33K
Strike price
Held after
0.00
Exercisable
—
9/15/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock1.33K shares | 9/15/2025 | M · Option Exercise | −1.33K | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned6.02K
Total
6.02K indirect6.02K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 6.02K | Indirect |
| Total | 6.02K | 6.02K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported